Disease | limited scleroderma |
Comorbidity | C0206062|interstitial lung disease |
Sentences | 1 |
PubMedID- 21593063 | We would like to report our experience of using rituximab in cyclophosphamide refractory, rapidly progressive interstitial lung disease (ild) in a patient with limited scleroderma. |
Page: 1